Back to Search
Start Over
AbbVie's Humira defense may keep prices high, but it's still legal, judge rules
- Source :
- Fiercepharma.com. June 9, 2020
- Publication Year :
- 2020
-
Abstract
- Byline: Eric Sagonowsky AbbVie reaps billions of dollars annually from its big-selling immunology medicine Humira, and, under deals with biosimilar makers, the drug is likely free from U.S. competition until [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Fiercepharma.com
- Publication Type :
- News
- Accession number :
- edsgcl.628908390